Heliyon 10 heliyon H He Hel Heli BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 () 2 10 1 1 0 0 0
Available online available A Av Ava Avai BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 5 0 1 0 0 1
2405-8440/© 2024 2405-8440/© 2 24 240 2405 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 0 0 -/. 3 5 0 1 0 0 1
Published by published P Pu Pub Publ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 4 0 1 0 0 1
This is this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 1 0 0 1
(http://creativecommons.org/licenses/by/4.0/). (http://creativecommons.org/licenses/by/4.0/). (http://creativecommons.org/licenses/by/4.0/). ( (h (ht (htt BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 1 0 0 (://.///./). 12 8 0 1 0 0 1
Research article research R Re Res Rese BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 0 no 0 10 1 0 0 0 1
Propionyl-L-carnitine mitigates propionyl-l-carnitine P Pr Pro Prop BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 --- 3 10 1 0 0 0 1
epigastric island epigastric e ep epi epig BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 3 1 0 0 0 1
Atilla Adnan atilla A At Ati Atil BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 ,,*,,, 6 10 1 0 0 0 1
Feng Zhang feng F Fe Fen Feng BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 ,. 2 4 1 0 0 0 1
a Arel a a a a a BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 0 1 ,,,, 4 6 1 0 0 0 1
b Aydin b b b b b BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 0 1 ,,,, 4 6 1 0 0 0 1
c Bilim c c c c c BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 0 1 ,,, 3 4 1 0 0 0 1
d Bahcesehir d d d d d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 0 1 ,,,, 4 6 1 0 0 0 1
e PhD e e e e e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 0 1 ,,,,,, 6 9 1 0 0 0 1
f Vanderbilt f f f f f BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 0 1 ,,,,, 5 10 1 0 0 0 1
USA USA usa U US USA USA BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 no 0 10 0 0 0 0 1
A R a A A A A BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 0 3 no 0 10 0 0 0 0 1
Keywords: Keywords: keywords: K Ke Key Keyw BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 : 1 3 0 0 0 0 1
Carnitine Carnitine carnitine C Ca Car Carn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 no 0 3 0 0 0 0 1
Flap survival flap F Fl Fla Flap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 5 0 0 0 0 1
Inflammation Inflammation inflammation I In Inf Infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 4 0 0 0 0 1
Ischemia-reperfusion injury ischemia-reperfusion I Is Isc Isch BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 - 1 10 0 0 0 0 1
Necrosis Necrosis necrosis N Ne Nec Necr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 no 0 3 0 0 0 0 1
Oxidative stress oxidative O Ox Oxi Oxid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 no 0 6 0 0 0 0 1
A B a A A A A BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 0 4 no 0 10 0 0 0 0 1
Background: Ischemia-reperfusion background: B Ba Bac Back BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 :-- 3 9 0 0 0 0 1
narios, notably narios, n na nar nari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ,. 2 10 0 0 0 0 1
benefits of benefits b be ben bene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 4 ---, 4 10 0 0 0 0 1
efficacy in efficacy e ef eff effi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 . 1 6 0 0 0 0 1
Methods: Sixteen methods: M Me Met Meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 :- 2 9 0 0 0 0 1
divided into divided d di div divi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 :---- 5 9 0 0 0 0 1
carnitine prior carnitine c ca car carn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 . 1 8 0 0 0 0 1
comprehensive evaluation comprehensive c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 9 0 0 0 0 1
assessments encompassing assessments a as ass asse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ,(- 3 9 0 0 0 0 1
dehyde), glutathione, dehyde), d de deh dehy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ),,,. 5 8 0 0 0 0 1
Results: The results: R Re Res Resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 :-- 3 9 0 0 0 0 1
when compared when w wh whe when BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 .-- 3 8 0 0 0 0 1
malondialdehyde levels malondialdehyde m ma mal malo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 . 1 9 0 0 0 0 1
Furthermore, the furthermore, F Fu Fur Furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 ,--, 4 9 0 0 0 0 1
nitric oxide nitric n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ,- 2 9 0 0 0 0 1
flammatory response. flammatory f fl fla flam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 .,- 3 9 0 0 0 0 1
crosis, polymorphonuclear crosis, c cr cro cros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ,--. 4 9 0 0 0 0 1
Additionally, vascularity additionally, A Ad Add Addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 ,--. 4 7 0 0 0 0 1
Conclusion: This conclusion: C Co Con Conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 :-- 3 9 0 0 0 0 1
effectively mitigates effectively e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 - 1 9 0 0 0 0 1
flaps. This flaps. f fl fla flap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ., 2 9 0 0 0 0 1
inflammation, as inflammation, i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ,.-- 4 9 0 0 0 0 1
promising therapeutic promising p pr pro prom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 9 0 0 0 0 1
warranting further warranting w wa war warr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 -. 2 6 0 0 0 0 1
* Corresponding * * * * * BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 9 *.,,,,. 7 8 0 0 0 0 1
E-mail addresses: e-mail E E- E-m E-ma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 -:@.(..),@.(.),@. 17 10 0 0 0 0 1
(O. Erbas), (o. ( (O (O. (O. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 (.),@.(..),.@.(.),..@. 22 9 0 0 0 0 1
(W.C. Lineaweaver). (w.c. ( (W (W. (W.C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 (..). 5 1 0 0 0 0 1
Contents lists contents C Co Con Cont BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 no 0 10 1 1 0 0 1
Heliyon Heliyon heliyon H He Hel Heli BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 11 no 0 10 1 0 0 0 1
journal homepage: journal j jo jou jour BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 11 :../ 4 10 1 0 0 0 1
https://doi.org/10.1016/j.heliyon.2024.e27448 https://doi.org/10.1016/j.heliyon.2024.e27448 https://doi.org/10.1016/j.heliyon.2024.e27448 h ht htt http BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 1 11 ://././... 10 4 0 1 0 0 1
Received 8 received R Re Rec Rece BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 ;; 2 10 0 1 0 0 1
Heliyon 10 heliyon H He Hel Heli BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 () 2 10 0 1 0 0 0
2 2 2 2 2 2 2 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 0 0 0 0 0
1. Introduction 1. 1 1. 1. 1. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 . 1 10 0 1 0 0 1
Ischemia-reperfusion injury ischemia-reperfusion I Is Isc Isch BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 -/. 3 9 0 1 0 0 1
multifaceted problem multifaceted m mu mul mult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,, 2 9 0 1 0 0 1
and endothelium. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .. 2 9 0 1 0 0 1
interplay between interplay i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -(/)[].- 8 9 0 1 0 0 1
plays a plays p pl pla play BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 0 1 0 0 1
research efforts research r re res rese BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 0 ,,,- 4 9 0 1 0 0 1
plications in plications p pl pli plic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 [].- 4 9 0 1 0 0 1
revascularization is revascularization r re rev reva BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 '[]. 4 8 0 1 0 0 1
Propionyl-L-carnitine (PLC), propionyl-l-carnitine P Pr Pro Prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 --(),---, 9 8 0 1 0 0 1
present in present p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .--,-- 6 10 0 1 0 0 1
and palmitoyl-L-carnitine. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 --. 3 9 0 1 0 0 1
also synthesized also a al als also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,[].--' 7 9 0 1 0 0 1
co-transporter aiding co-transporter c co co- co-t BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 --.- 4 9 0 1 0 0 1
chondria, these chondria, c ch cho chon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,- 2 9 0 1 0 0 1
cycle. This cycle. c cy cyc cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .() 3 9 0 1 0 0 1
oxidative phosphorylation. oxidative o ox oxi oxid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 .,., 4 9 0 1 0 0 1
is converted is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()[].,--- 9 9 0 1 0 0 1
strates its strates s st str stra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (), 3 9 0 1 0 0 1
catalase and catalase c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ()., 4 9 0 1 0 0 1
ferrous ions. ferrous f fe fer ferr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 .,-- 4 9 0 1 0 0 1
alpha-tocopherol [6]. alpha-tocopherol a al alp alph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -[]. 4 9 0 1 0 0 1
elucidated, it elucidated, e el elu eluc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,, 2 9 0 1 0 0 1
presence of presence p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ./ 2 9 0 1 0 0 1
properties. By properties. p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .,/ 3 9 0 1 0 0 1
[7]. [7]. [7]. [ [7 [7] [7]. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 []. 3 0 0 1 0 0 1
To contribute to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 ,- 2 9 0 1 0 0 1
island flaps island i is isl isla BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,[]. 4 9 0 1 0 0 1
aforementioned information aforementioned a af afo afor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 , 1 9 0 1 0 0 1
model in model m mo mod mode BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 1 0 1 0 0 1
2. Materials 2. 2 2. 2. 2. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 . 1 10 0 0 0 0 1
The biostatistics the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 , 1 9 0 0 0 0 1
ensuring statistical ensuring e en ens ensu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 .-,,. 5 10 0 0 0 0 1
experimental procedures experimental e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 no 0 9 0 0 0 0 1
laboratory animals. laboratory l la lab labo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 .( 2 10 0 0 0 0 1
Tool, Model tool, T To Too Tool BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 ,-,.,,), 8 10 0 0 0 0 1
preventative measure preventative p pr pre prev BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 . 1 3 0 0 0 0 1
3. Experimental 3. 3 3. 3. 3. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 9 . 1 10 0 0 0 0 1
3.1. The 3.1. 3 3. 3.1 3.1. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 9 .. 2 10 0 0 0 0 1
• The • • • • • BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 •,. 3 5 0 0 0 0 1
• In • • • • • BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 •,--, 5 10 0 0 0 0 1
induced. induced. induced. i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 . 1 0 0 0 0 0 1
• In • • • • • BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 •,,. 4 9 0 0 0 0 1
• Biochemical • • • • • BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 •. 2 5 0 0 0 0 1
• On • • • • • BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 •,,., 5 9 0 0 0 0 1
tissue samples tissue t ti tis tiss BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 . 1 4 0 0 0 0 1
3.2. Surgical 3.2. 3 3. 3.2 3.2. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 10 .. 2 10 0 0 0 0 1
All surgical all A Al All All BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 10 ().(/; 6 9 0 0 0 0 1
Alfazyne®, Alfasan alfazyne®, A Al Alf Alfa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 10 ,,)(/;,-,). 11 9 0 0 0 0 1
abdominal and abdominal a ab abd abdo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 .- 2 9 0 0 0 0 1
hexidine gluconate hexidine h he hex hexi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 10 (,,,)., 7 10 0 0 0 0 1
the operating the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 . 1 10 0 0 0 0 1
A.A. Eyuboglu a.a. A A. A.A A.A. BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 ... 3 10 0 1 1 1 0
Heliyon 10 heliyon H He Hel Heli BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 () 2 10 0 1 0 0 0
3 3 3 3 3 3 3 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 0 no 0 10 1 1 0 0 0
previous studies previous p pr pre prev BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 [,].(),(/.) 11 9 0 0 0 0 1
from Sigma from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 .,().,, 7 9 0 0 0 0 1
subcutaneous and subcutaneous s su sub subc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ., 2 9 0 0 0 0 1
the epigastric the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ., 2 9 0 0 0 0 1
V2 micro v2 V V2 V2 V2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 (.).( 5 4 0 0 0 0 1
Following a following F Fo Fol Foll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 -,,-. 5 9 0 0 0 0 1
increase in increase i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -. 2 9 0 0 0 0 1
group (group group g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (),.. 5 9 0 0 0 0 1
group remained group g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ., 2 9 0 0 0 0 1
samples were samples s sa sam samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 0 . 1 9 0 0 0 0 1
days, the days, d da day days BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,. 2 9 0 0 0 0 1
ensure the ensure e en ens ensu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,- 2 10 0 0 0 0 1
were taken were w we wer were BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 2 0 0 0 0 1
3.3. Macroscopic 3.3. 3 3. 3.3 3.3. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 .. 2 10 0 0 0 0 1
Seven days seven S Se Sev Seve BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 ,. 2 10 0 0 0 0 1
The surviving the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 -(.,,). 7 9 0 0 0 0 1
obtain this obtain o ob obt obta BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 ,[[]]. 6 6 0 0 0 0 1
3.4. Histopathological 3.4. 3 3. 3.4 3.4. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 .. 2 10 0 0 0 0 1
Lipid peroxidation, lipid L Li Lip Lipi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 ,,,. 4 10 0 0 0 0 1
3.5. Measurement 3.5. 3 3. 3.5 3.5. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 ..() 4 10 0 0 0 0 1
Lipid peroxidation lipid L Li Lip Lipi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 ,, 2 8 1 0 0 0 1
levels as levels l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 ()., 4 9 1 0 0 0 1
tissue samples, tissue t ti tis tiss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 ,•. 3 10 1 0 0 0 1
bath, the bath, b ba bat bath BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 , 1 9 1 0 0 0 1
535 nm. 535 5 53 535 535 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 8 . 1 8 1 0 0 0 1
expressed in expressed e ex exp expr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 []. 3 3 1 0 0 0 1
3.6. Measurement 3.6. 3 3. 3.6 3.6. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 ..() 4 10 1 0 0 0 1
The determination the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 , 1 10 1 0 0 0 1
Fig. 1. fig. F Fi Fig Fig. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 ..-(.,,).() 11 10 1 1 0 0 1
group, and group, g gr gro grou BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 11 ,(). 4 2 1 1 0 0 1
A.A. Eyuboglu a.a. A A. A.A A.A. BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 ... 3 10 0 1 1 0 0
Heliyon 10 heliyon H He Hel Heli BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 () 2 10 1 1 0 0 0
4 4 4 4 4 4 4 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 0 no 0 10 0 1 0 0 0
spectrophotometrically employing spectrophotometrically s sp spe spec BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 '.,,--(- 8 10 0 0 0 0 1
acid) (DTNB), acid) a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 )(),. 5 9 0 0 0 0 1
quantified via quantified q qu qua quan BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 []. 3 8 0 0 0 0 1
Fig. 2. fig. F Fi Fig Fig. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 ...() 5 9 1 0 0 0 1
eosin (HE) eosin e eo eos eosi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 (),.(; 6 9 1 0 0 0 1
leukocyte [PMNL] leukocyte l le leu leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 [];.)()(), 10 9 1 0 0 0 1
original magnification original o or ori orig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 .(,''.)() 9 9 1 0 0 0 1
Carnitine group carnitine C Ca Car Carn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 2 ,.( 3 9 1 0 0 0 1
group in group g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ,.)() 5 9 1 0 0 0 1
Carnitine group carnitine C Ca Car Carn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 2 ,.( 3 9 1 0 0 0 1
group in group g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ,''.)()- 8 10 1 0 0 0 1
nitric oxide nitric n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 (),.(-[].)() 12 9 1 0 0 0 1
Displays anti-iNOS displays D Di Dis Disp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 -,.(-[].).( 11 9 1 0 0 0 1
interpretation of interpretation i in int inte BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ,.) 3 8 1 0 0 0 1
A.A. Eyuboglu a.a. A A. A.A A.A. BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 ... 3 10 1 1 1 0 0
Heliyon 10 heliyon H He Hel Heli BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 () 2 10 0 0 0 0 0
5 5 5 5 5 5 5 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 0 1 0 0 0
3.7. Nitric 3.7. 3 3. 3.7 3.7. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 ..() 4 10 0 0 0 0 1
Tissue samples, tissue T Ti Tis Tiss BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 ,,- 3 9 0 0 0 0 1
mark. The mark. m ma mar mark BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ., 2 10 0 0 0 0 1
Greiss reagent greiss G Gr Gre Grei BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 .,' 3 10 0 0 0 0 1
content was content c co con cont BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 []. 3 6 0 0 0 0 1
3.8. Myeloperoxidase 3.8. 3 3. 3.8 3.8. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 1 ..() 4 10 0 0 0 0 1
Tissue-associated MPO tissue-associated T Ti Tis Tiss BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 1 -.[]- 5 9 0 0 0 0 1
mogenized in mogenized m mo mog moge BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 1 (;.),. 6 9 0 0 0 0 1
reconstituted in reconstituted r re rec reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 ..- 3 9 0 0 0 0 1
cycles with cycles c cy cyc cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 ,,.,. 5 10 0 0 0 0 1
prepared samples prepared p pr pre prep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 .,-,. 5 9 0 0 0 0 1
One unit one O On One One BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 1 ,, 2 9 0 0 0 0 1
period of period p pe per peri BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 .(/). 5 6 0 0 0 0 1
3.9. Peripheral 3.9. 3 3. 3.9 3.9. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 .. 2 10 0 0 0 0 1
Peripheral blood peripheral P Pe Per Peri BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 4 -,- 3 9 0 0 0 0 1
assessing circulating assessing a as ass asse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 .,--(), 7 9 0 0 0 0 1
neutrophil counts neutrophil n ne neu neut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 4 . 1 10 0 0 0 0 1
from these from f fr fro from BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 []. 3 1 0 0 0 0 1
3.10. Histopathological 3.10. 3 3. 3.1 3.10 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 .. 2 10 0 0 0 0 1
Histopathological analyses histopathological H Hi His Hist BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 .[] 3 10 0 0 0 0 1
biopsy samples biopsy b bi bio biop BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 9 0 0 0 0 1
were sectioned. were w we wer were BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 .. 2 10 0 0 0 0 1
sections were sections s se sec sect BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 ,. 2 10 0 0 0 0 1
hematoxylin and hematoxylin h he hem hema BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 --(-, 5 9 0 0 0 0 1
Olympus C-5050 olympus O Ol Oly Olym BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 6 -),,() 6 9 0 0 0 0 1
vascularization, employing vascularization, v va vas vasc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 ,[].(). 7 9 0 0 0 0 1
nitric oxide nitric n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 (), 3 9 0 0 0 0 1
peroxidase activity. peroxidase p pe per pero BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 .,., 4 9 0 0 0 0 1
sections were sections s se sec sect BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 -, 2 10 0 0 0 0 1
min, followed min, m mi min min, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 ,.,(-,/) 8 9 0 0 0 0 1
at 4 at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 •.-,., 6 9 0 0 0 0 1
specific for specific s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 .,-. 4 9 0 0 0 0 1
evaluation of evaluation e ev eva eval BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 - 1 9 0 0 0 0 1
light microscope light l li lig ligh BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 6 -. 2 4 0 0 0 0 1
4. Statistical 4. 4 4. 4. 4. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 9 . 1 10 0 1 0 0 1
Statistical analysis statistical S St Sta Stat BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 '-.- 4 9 0 1 0 0 1
rameters such rameters r ra ram rame BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 9 ,,,,, 5 9 0 1 0 0 1
assessed through assessed a as ass asse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 -.-, 4 9 0 1 0 0 1
Tukey tests tukey T Tu Tuk Tuke BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 .(), 4 10 0 1 0 0 1
significance was significance s si sig sign BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 .. 2 2 0 1 0 0 1
Table 1 table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 1 0 1 0 0 1
Histopathological scoring histopathological H Hi His Hist BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 ,. 2 10 0 1 0 0 1
Score Score score S Sc Sco Scor BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 3 0 1 0 0 1
Necrosis Necrosis necrosis N Ne Nec Necr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 no 0 5 0 1 0 0 1
Edema Edema edema E Ed Ede Edem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 no 0 3 0 1 0 0 1
PMNL a pmnl P PM PMN PMNL BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 no 0 4 0 1 0 0 1
Vascularization Vascularization vascularization V Va Vas Vasc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 no 0 10 0 1 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 11 no 0 1 0 1 0 0 1
None None none N No Non None BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 4 0 1 0 0 1
None None none N No Non None BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 4 0 1 0 0 1
Normal Normal normal N No Nor Norm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 5 0 1 0 0 1
None None none N No Non None BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 4 0 1 0 0 1
1 1 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 11 no 0 1 0 1 0 0 1
Superficial Superficial superficial S Su Sup Supe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 10 0 1 0 0 1
Light Light light L Li Lig Ligh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 11 no 0 5 0 1 0 0 1
Light Light light L Li Lig Ligh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 11 no 0 5 0 1 0 0 1
Light Light light L Li Lig Ligh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 11 no 0 5 0 1 0 0 1
2 2 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 11 no 0 1 0 1 0 0 1
Pronounced Pronounced pronounced P Pr Pro Pron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 9 0 1 0 0 1
Pronounced Pronounced pronounced P Pr Pro Pron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 9 0 1 0 0 1
Pronounced Pronounced pronounced P Pr Pro Pron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 9 0 1 0 0 1
Pronounced Pronounced pronounced P Pr Pro Pron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 9 0 1 0 0 1
3 3 3 3 3 3 3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 11 no 0 1 0 1 0 0 1
Massive Massive massive M Ma Mas Mass BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 6 0 1 0 0 1
Dense Dense dense D De Den Dens BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 5 0 1 0 0 1
Massive Massive massive M Ma Mas Mass BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 6 0 1 0 0 1
Dense Dense dense D De Den Dens BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 5 0 1 0 0 1
a PMNL a a a a a BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 5 11 -. 2 10 0 1 0 0 1
A.A. Eyuboglu a.a. A A. A.A A.A. BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 ... 3 10 0 0 1 0 0
Heliyon 10 heliyon H He Hel Heli BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 () 2 10 0 0 0 0 0
6 6 6 6 6 6 6 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 0 no 0 10 0 1 0 0 0
5. Results 5. 5 5. 5. 5. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 . 1 10 0 0 0 0 1
Throughout the throughout T Th Thr Thro BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 ,,. 3 10 0 0 0 0 1
5.1. Flap 5.1. 5 5. 5.1 5.1. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .. 2 10 0 0 0 0 1
The flap the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 (.)., 5 10 0 0 0 0 1
mean survival mean m me mea mean BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ..,,... 7 10 0 0 0 0 1
the results the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 (.). 4 4 0 0 0 0 1
5.2. Biochemical 5.2. 5 5. 5.2 5.2. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 .. 2 10 0 0 0 0 1
In the in I In In In BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 1 ,../,../,../, 13 10 0 0 0 0 1
NO level no N NO NO NO BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 1 ../.,,../, 10 10 0 0 0 0 1
was 2.3 was w wa was was BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 ../,../,../., 13 10 0 0 0 0 1
differences were differences d di dif diff BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 (). 3 10 0 0 0 0 1
5.3. Peripheral 5.3. 5 5. 5.3 5.3. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 .. 2 10 0 0 0 0 1
In the in I In In In BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 6 3 ,,/,,, 6 10 0 0 0 0 1
± 1355 ± ± ± ± ± BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 3 /.,-.. 6 8 0 0 0 0 1
5.4. Histopathological 5.4. 5 5. 5.4 5.4. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 .. 2 10 0 0 0 0 1
In an in I In In In BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 6 3 ,,, 3 9 0 0 0 0 1
each group each e ea eac each BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 (),. 4 9 0 0 0 0 1
the 16 the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 ,...., 6 9 0 0 0 0 1
the scores the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 ,..,...., 9 9 0 0 0 0 1
exhibited mean exhibited e ex exh exhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 ..,..,..., 10 10 0 0 0 0 1
apparent that apparent a ap app appa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 (.) 3 9 0 0 0 0 1
(Table 3; (table ( (T (Ta (Tab BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 3 (;.). 5 1 0 0 0 0 1
6. Discussion 6. 6 6. 6. 6. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 . 1 10 0 0 0 0 1
The success the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 5 ,, 2 9 0 0 0 0 1
87%. However, 87%. 8 87 87% 87%. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,, 3 9 0 0 0 0 1
rates as rates r ra rat rate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 . 1 9 0 0 0 0 1
tissue and tissue t ti tis tiss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 []. 3 5 0 0 0 0 1
Ischemia/reperfusion injury ischemia/reperfusion I Is Isc Isch BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 /. 2 10 0 0 0 0 1
generation of generation g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 , 1 9 0 0 0 0 1
damage or damage d da dam dama BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 .. 2 9 0 0 0 0 1
crucial role crucial c cr cru cruc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 .,, 3 9 0 0 0 0 1
byproducts, which byproducts, b by byp bypr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 ,,-,- 5 9 0 0 0 0 1
microvascular permeability microvascular m mi mic micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 [[]. 4 9 0 0 0 0 1
into the into i in int into BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 9 0 0 0 0 1
radicals on radicals r ra rad radi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 .,,[-]. 7 9 0 0 0 0 1
L-carnitine plays l-carnitine L L- L-c L-ca BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 8 -, 2 9 0 1 0 0 1
transporting long-chain transporting t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 -'.- 4 10 0 1 0 0 1
subsequent energy subsequent s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 .--, 4 9 0 1 0 0 1
reducing oxidative reducing r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 .-- 3 9 0 1 0 0 1
and reduced and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 -, 2 9 0 1 0 0 1
increased the increased i in inc incr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 [].-- 5 9 0 1 0 0 1
Table 2 table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 no 0 0 0 1 0 0 1
Biochemical assesment biochemical B Bi Bio Bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 (),(),()() 10 10 0 1 0 0 1
of sham of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 --(). 5 3 0 1 0 0 1
Biochemical Parameters biochemical B Bi Bio Bioc BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 no 0 10 0 1 0 0 1
Mean MDA mean M Me Mea Mean BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 (/) 3 7 0 1 0 0 1
GSH level gsh G GS GSH GSH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 10 (/) 3 8 0 1 0 0 1
MPO level mpo M MP MPO MPO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 10 (/) 3 6 0 1 0 0 1
NO level no N NO NO NO BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 (/) 3 7 0 1 0 0 1
Sham group sham S Sh Sha Sham BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 11 no 0 7 0 1 0 0 1
146.2 ± 146.2 1 14 146 146. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 .. 2 9 0 1 0 0 1
1.4 ± 1.4 1 1. 1.4 1.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 .. 2 7 0 1 0 0 1
30.8 ± 30.8 3 30 30. 30.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 .. 2 7 0 1 0 0 1
21.5 ± 21.5 2 21 21. 21.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 .. 2 8 0 1 0 0 1
PLC group plc P PL PLC PLC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 11 no 0 7 0 1 0 0 1
*118.6 ± *118.6 * *1 *11 *118 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 *.. 3 10 0 1 0 0 1
*2.3 ± *2.3 * *2 *2. *2.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 *.. 3 7 0 1 0 0 1
*23.2 ± *23.2 * *2 *23 *23. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 *.. 3 8 0 1 0 0 1
*29.2 ± *29.2 * *2 *29 *29. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 *.. 3 8 0 1 0 0 1
*p < *p * *p *p *p BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 11 *.. 3 10 0 1 0 0 1
A.A. Eyuboglu a.a. A A. A.A A.A. BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 11 ... 3 10 0 0 1 0 0
Heliyon 10 heliyon H He Hel Heli BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 () 2 10 0 1 0 0 0
7 7 7 7 7 7 7 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 0 no 0 10 0 0 0 0 0
the toxic the t th the the BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,,[].- 6 9 0 1 0 0 1
nyl-L-carnitine also nyl-l-carnitine n ny nyl nyl- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 --. 3 9 0 1 0 0 1
tissue can tissue t ti tis tiss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,, 2 9 0 1 0 0 1
including nucleic including i in inc incl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,., 3 9 0 1 0 0 1
preventing I/R preventing p pr pre prev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 /. 2 9 0 1 0 0 1
I/R-induced heart i/r-induced I I/ I/R I/R- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 /-[,,]. 7 7 0 1 0 0 1
This study this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 -, 2 8 0 1 0 0 1
various macroscopic, various v va var vari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,. 2 9 0 1 0 0 1
that pre-ischemic that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 --/., 5 9 0 1 0 0 1
epigastric flaps epigastric e ep epi epig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 , 1 8 0 1 0 0 1
evaluations following evaluations e ev eva eval BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -,[,,,]. 8 8 0 1 0 0 1
The designated the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 ,- 2 8 0 1 0 0 1
implemented in implemented i im imp impl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .-,- 4 8 0 1 0 0 1
nition that nition n ni nit niti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 -. 2 9 0 1 0 0 1
changes, encompassing changes, c ch cha chan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,,.- 4 8 0 1 0 0 1
quently, a quently, q qu que quen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 , 1 8 0 1 0 0 1
observed physiological observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 [,,,,]. 7 9 0 1 0 0 1
reperfusion, while reperfusion, r re rep repe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,- 2 9 0 1 0 0 1
chemical analysis chemical c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 0 1 0 0 1
areas. The areas. a ar are area BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .-(., 5 8 0 1 0 0 1
Cybernetics, USA). cybernetics, C Cy Cyb Cybe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 ,). 3 9 0 1 0 0 1
group. group. group. g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 0 0 1 0 0 1
Detecting the detecting D De Det Dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 -., 3 9 0 1 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,. 2 9 0 1 0 0 1
known to known k kn kno know BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 /., 3 9 0 1 0 0 1
to evaluate to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 [,]., 5 9 0 1 0 0 1
group. It group. g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .(), 4 10 0 1 0 0 1
radicals and radicals r ra rad radi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -[].,.[] 8 9 0 1 0 0 1
diminished tissue diminished d di dim dimi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 /. 2 4 0 1 0 0 1
In the in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 0 , 1 9 0 1 0 0 1
group. Myeloperoxidase group. g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .. 2 9 0 1 0 0 1
from neutrophils from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 0 1 0 0 1
as a as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -.,.[]/ 7 9 0 1 0 0 1
rats and rats r ra rat rats BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,..[] 5 9 0 1 0 0 1
the results the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,- 2 9 0 1 0 0 1
rats. Their rats. r ra rat rats BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ., 2 9 0 1 0 0 1
animals that animals a an ani anim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 --, 3 9 0 1 0 0 1
group. group. group. g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 0 0 1 0 0 1
Nitric oxide nitric N Ni Nit Nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 no 0 9 0 1 0 0 1
superoxide anion superoxide s su sup supe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 [].[]. 6 9 0 1 0 0 1
conducted by conducted c co con cond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .[],--, 7 9 0 1 0 0 1
cyclic adenosine cyclic c cy cyc cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .,.[] 5 9 0 1 0 0 1
of random of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ., 2 9 0 1 0 0 1
group. group. group. g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 0 0 1 0 0 1
Histopathological assessment histopathological H Hi His Hist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,- 2 8 0 1 0 0 1
crosis, polymorphonuclear crosis, c cr cro cros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,(),,., 7 8 0 1 0 0 1
reduced scores reduced r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,- 2 9 0 1 0 0 1
effects. Notably, effects. e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .,, 3 9 0 1 0 0 1
supply, thereby supply, s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,. 2 9 0 1 0 0 1
and an and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -[[,]]. 7 9 0 1 0 0 1
observed in observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 /. 2 9 0 1 0 0 1
outcome, suggesting outcome, o ou out outc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,/. 3 8 0 1 0 0 1
Table 3 table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 10 no 0 0 0 1 0 0 1
Histopatological examination histopatological H Hi His Hist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 10 --(),,() 8 10 0 1 0 0 1
infiltration, vascularization. infiltration, i in inf infi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 ,. 2 2 0 1 0 0 1
Histopatological examination histopatological H Hi His Hist BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 no 0 10 0 1 0 0 1
Necrosis Necrosis necrosis N Ne Nec Necr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 no 0 3 0 1 0 0 1
Edema Edema edema E Ed Ede Edem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 no 0 2 0 1 0 0 1
PMNL PMNL pmnl P PM PMN PMNL BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 no 0 1 0 1 0 0 1
Vascularization Vascularization vascularization V Va Vas Vasc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 no 0 5 0 1 0 0 1
Sham group sham S Sh Sha Sham BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 11 no 0 9 0 1 0 0 1
3.75 ± 3.75 3 3. 3.7 3.75 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 11 .. 2 9 0 1 0 0 1
3.62 ± 3.62 3 3. 3.6 3.62 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 11 .. 2 9 0 1 0 0 1
3.1 ± 3.1 3 3. 3.1 3.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 11 .. 2 8 0 1 0 0 1
1 ± 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 9 11 . 1 6 0 1 0 0 1
PLC group plc P PL PLC PLC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 no 0 8 0 1 0 0 1
*2 ± *2 * *2 *2 *2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 11 *. 2 7 0 1 0 0 1
*1.75 ± *1.75 * *1 *1. *1.7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 11 *.. 3 10 0 1 0 0 1
*1.87 ± *1.87 * *1 *1. *1.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 11 *.. 3 10 0 1 0 0 1
*2.37 ± *2.37 * *2 *2. *2.3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 11 *.. 3 10 0 1 0 0 1
*p < *p * *p *p *p BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 11 *.. 3 10 0 1 0 0 1
A.A. Eyuboglu a.a. A A. A.A A.A. BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 ... 3 10 0 1 1 0 0
Heliyon 10 heliyon H He Hel Heli BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 () 2 10 0 1 0 0 0
8 8 8 8 8 8 8 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 9 0 no 0 10 0 0 0 0 0
While multiple while W Wh Whi Whil BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 /,, 3 9 0 1 0 0 1
knowledge, this knowledge, k kn kno know BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ,-,,- 5 9 0 1 0 0 1
logical levels. logical l lo log logi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .,., 4 10 0 1 0 0 1
relatively small. relatively r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ., 2 8 0 1 0 0 1
biochemical markers. biochemical b bi bio bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 9 0 1 0 0 1
the realm the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 /. 2 1 0 1 0 0 1
7. Conclusion 7. 7 7. 7. 7. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 . 1 10 0 0 0 0 1
In summary, in I In In In BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 1 ,-- 3 9 0 0 0 0 1
of I/R of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 /.,. 4 10 0 0 0 0 1
Ethical approval ethical E Et Eth Ethi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 no 0 10 0 0 0 0 1
This study this T Th Thi This BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 #.- 3 10 0 0 0 0 1
formed in formed f fo for form BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 /. 2 8 0 0 0 0 1
Funding Funding funding F Fu Fun Fund BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 no 0 10 0 0 0 0 1
No funding no N No No No BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 . 1 10 0 0 0 0 1
Additional information additional A Ad Add Addi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 no 0 10 0 0 0 0 1
No additional no N No No No BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 . 1 10 0 0 0 0 1
8. Data 8. 8 8. 8. 8. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 . 1 10 0 0 0 0 1
There is there T Th The Ther BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 ,. 2 10 0 0 0 0 1
CRediT authorship credit C CR CRe CRed BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 no 0 10 0 0 0 0 1
Atilla Adnan atilla A At Ati Atil BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 4 :-,-,,,,, 9 9 0 0 0 0 1
Investigation, Funding investigation, I In Inv Inve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 4 ,.:-,,,,, 9 10 0 0 0 0 1
administration, Methodology, administration, a ad adm admi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 4 ,,,,,,.: 8 9 0 0 0 0 1
Writing -review writing W Wr Wri Writ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 4 -,,,.:-,, 9 9 0 0 0 0 1
Supervision. Feng supervision. S Su Sup Supe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 4 .:,,,,,..- 10 9 0 0 0 0 1
eaweaver: Visualization, eaweaver: e ea eaw eawe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 4 :,,,,,. 7 8 0 0 0 0 1
Declaration of declaration D De Dec Decl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 no 0 10 0 0 0 0 1
The authors the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 no 0 10 0 0 0 0 1
influence the influence i in inf infl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 . 1 3 0 0 0 0 1
Acknowledgments Acknowledgments acknowledgments A Ac Ack Ackn BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 10 0 0 0 0 1
Not available. not N No Not Not BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 . 1 10 0 0 0 0 1
References References references R Re Ref Refe BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 10 0 0 0 0 1
[1] W.A. [1] [ [1 [1] [1] BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 []..,..,..,.,.,.., 18 9 0 0 0 0 1
muscle and muscle m mu mus musc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ,...(). 7 4 0 0 0 0 1
[2] C. [2] [ [2 [2] [2] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 [].,.,.,..,.,..,.,.,.,.,.,., 28 8 0 0 0 0 1
Deficiency of deficiency D De Def Defi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 ,..()(),://././-- 17 8 0 0 0 0 1
92159-2. 92159-2. 92159-2. 9 92 921 9215 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 6 -. 2 0 0 0 0 0 1
[3] G. [3] [ [3 [3] [3] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 [].,.,.,.-.,.-.,-,() 20 10 0 0 0 0 1
(2018) 2147-2153. (2018) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 6 ()-. 4 1 0 0 0 0 1
[4] A. [4] [ [4 [4] [4] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 [].,.-,--: 10 9 0 0 0 0 1
data to data d da dat data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ,...()()-,://././... 20 7 0 0 0 0 1
[5] Mayes [5] [ [5 [5] [5] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 []..:,,,(),'.., 15 9 0 0 0 0 1
Stanford; pp. stanford; S St Sta Stan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 ;... 4 1 0 0 0 0 1
[6] I. [6] [ [6 [6] [6] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 [].,-,.()()-,://././..... 25 8 0 0 0 0 1
[7] A. [7] [ [7 [7] [7] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 [].,.-,--: 10 9 0 0 0 0 1
potential clinical potential p po pot pote BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ,..()()-,://././..... 21 6 0 0 0 0 1
A.A. Eyuboglu a.a. A A. A.A A.A. BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 11 ... 3 10 0 1 1 0 0
Heliyon 10 heliyon H He Hel Heli BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 () 2 10 0 1 0 0 0
9 9 9 9 9 9 9 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 10 0 no 0 10 0 0 0 0 0
[8] O. [8] [ [8 [8] [8] BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [].,..,.,.,-: 13 9 0 1 0 0 1
study, Eur. study, s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ,....()-. 9 2 0 1 0 0 1
[9] O. [9] [ [9 [9] [9] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [].,..,.,.,-: 13 9 0 1 0 0 1
study, Genel study, s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ,.()()-. 8 2 0 1 0 0 1
[10] C. [10] [ [1 [10 [10] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [].,.,.,-,.()-. 15 9 0 1 0 0 1
[11] G.L. [11] [ [1 [11 [11] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 []..,,...()-. 13 4 0 1 0 0 1
[12] L.M. [12] [ [1 [12 [12] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 []..,..,.,.-,,.. 16 9 0 1 0 0 1
(1990) 285-295. (1990) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ()-. 4 0 0 1 0 0 1
[13] M. [13] [ [1 [13 [13] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [].,.,..,.,..,.,., 18 10 0 1 0 0 1
rat model, rat r ra rat rat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ,.........()-. 14 4 0 1 0 0 1
[14] O. [14] [ [1 [14 [14] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [].,.,.,..,,....()()-. 22 9 0 1 0 0 1
[15] M. [15] [ [1 [15 [15] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [].,.,.,.,..,.,.,- 18 9 0 1 0 0 1
island flap island i is isl isla BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ,...()-. 8 3 0 1 0 0 1
[16] M.F. [16] [ [1 [16 [16] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 []..,..,..,.,,...()-. 21 7 0 1 0 0 1
[17] C.J. [17] [ [1 [17 [17] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 []..,.,.,.,.,,.. 16 9 0 1 0 0 1
Plast. Surg. plast. P Pl Pla Plas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ..()-. 6 1 0 1 0 0 1
[18] E.G. [18] [ [1 [18 [18] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 []..,..,.,.,,...()(;) 21 9 0 1 0 0 1
60-65. 60-65. 60-65. 6 60 60- 60-6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -. 2 0 0 1 0 0 1
[19] H. [19] [ [1 [19 [19] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [].,.,..,.,.,.,- 16 9 0 1 0 0 1
rats, J. rats, r ra rat rats BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ,...()()-. 10 2 0 1 0 0 1
[20] R. [20] [ [2 [20 [20] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [].,.,.,.,.,.,-:,.... 21 9 0 1 0 0 1
Sci. 1033 sci. S Sc Sci Sci. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .()()-. 7 1 0 1 0 0 1
[21] M. [21] [ [2 [21 [21] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [].,,-/ 7 9 0 1 0 0 1
functions and functions f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ,()(). 6 6 0 1 0 0 1
[22] Y.K. [22] [ [2 [22 [22] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 []..,.,.,-,...() 16 9 0 1 0 0 1
(2007) 247-252. (2007) ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ()-. 4 0 0 1 0 0 1
[23] G. [23] [ [2 [23 [23] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [].,.,.,..,.,.,.,,. 19 9 0 1 0 0 1
Neurol. 71 neurol. N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .()()-. 7 1 0 1 0 0 1
[24] R.A. [24] [ [2 [24 [24] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 []..,.,..,.,..-,.,..,...,..,., 30 8 0 1 0 0 1
Myeloperoxidase is myeloperoxidase M My Mye Myel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,...()()-. 10 8 0 1 0 0 1
[25] S. [25] [ [2 [25 [25] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [].,..,.,--,..()(-) 19 9 0 1 0 0 1
151-155. 151-155. 151-155. 1 15 151 151- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -. 2 0 0 1 0 0 1
[26] R. [26] [ [2 [26 [26] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [].,.,.,/,..()()-. 18 7 0 1 0 0 1
[27] S. [27] [ [2 [27 [27] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [].,..,.,.,..,-/ 16 9 0 1 0 0 1
reperfusion injury, reperfusion r re rep repe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ,...()()-. 10 3 0 1 0 0 1
[28] K.T. [28] [ [2 [28 [28] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 []..,..,--,...()() 18 9 0 1 0 0 1
1638-1645. 1638-1645. 1638-1645. 1 16 163 1638 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 -. 2 0 0 1 0 0 1
A.A. Eyuboglu a.a. A A. A.A A.A. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 ... 3 10 0 1 1 0 0

